Mobilní aplikace jako vhodné intervenční nástroje pro nemocné trpící depresí
:
Petra Marešová; Blanka Klímová; Kamil Kuča
:
Čes. slov. Farm., 2017; 66, 55-61
:
Original Articles
V současnosti trpí duševními poruchami přibližně 450 milionů lidí po celém světě. Deprese patří mezi jeden z nejzávažnějších typů chronického onemocnění, představuje zásadní hrozbu zátěže ekonomických a sociálních systémů vlád po celém světě. Jeden z aktuálních nefarmakologických přístupů, který je využíván i u osob trpících depresemi, je tzv. mHealth, tedy používání mobilních zařízení pro léčebné a podpůrné účely. Jeho účinnost je prokázána zejména v časných stadiích deprese.
Cílem tohoto článku je analyzovat nejnovější randomizované kontrolované studie, které ukazují účinnost využití mobilních aplikací v diagnostice nebo léčbě deprese. Cíle je dosaženo pomocí rešerše studií zaměřených na dopady jednotlivých aplikací pro lidi s depresí a na specifikaci kritérií hodnocení kvality těchto aplikací. Výsledky randomizovaných kontrolovaných studií (RCT) ukazují, že existuje velký potenciál mobilních aplikací v oblasti péče o nemocné trpící depresí, zejména v raných stadiích onemocnění.
Existuje naléhavá potřeba četnějších a dlouhodobějších RCT v této oblasti za účelem prokázání nezvratné účinnosti těchto mobilních aplikací v léčbě deprese. Příspěvek poukazuje i na silné a slabé stránky mobilních aplikací v oblasti detekce, diagnostiky a léčby deprese.
Klíčová slova:
mobilní aplikace • deprese • léčba
Sources
1. mHealth Alliance. mHealth solutions for improving mental health and illnesses in the aging process, White Paper Series on mHealth and Aging, http://www.mhealthknowledge.org/sites/default/files/7_mHA-Aging-Paper3_092713.pdf (accessed 27 October 2016).
2. Lönnqvist J. Major psychiatric disorders in suicide and suicide attempters. In: D. Wasserman and C. Wasserman (eds.), Oxford Textbook of Suicidology and Suicide Prevention: A Global Approach (pp. 275–286). Oxford: Oxford University Press 2009.
3. Richards C. S., O’Hara M. The Oxford Handbook of Depression and Comorbidity. OUP 2014.
4. Klimova B., Maresova P., Valis M., Hort J., Kuca K. Alzheimer’s disease and language impairments: social intervention and medical treatment. Clin. Interv. Aging 2015; 10, 1401–1408.
5. Maresova P., Mohelska H., Dolejs J., Kuca K. Socio-economic aspects of Alzheimer’s disease. Current Alzheimer Research 2015; 12(9), 903–911.
6. Evans W. D., Abroms L. C., Poropatich R., Nielsen P. E., Wallace J. L. Mobile health evaluation methods: the Text4baby case study. J. Health Commun. 2012; 17(1), 22–29.
7. Research2guidance, mHealth App Developer Economics 2015, Free Report, p. 35.
8. WHO, mHealth New Horizonts for health through mobile technologies. http://www.who.int/goe/publications/goe_mhealth_web.pdf (accessed 27 October 2016).
9. Kohn R., Saxena S., Levav I., Saraceno B. The treatment gap in mental health care, Bulletin of the World Health Organization, vol. 82. 2004.
10. Dellabella H. Top 10 mental health apps, http://www.psychiatryadvisor.com/top-10-mental-health-apps/slideshow/2608/ (accessed 27 October 2016).
11. Powell A. C., Torous J., Chan S., Raynor G. S., Shwarts E., Shanahan M., Landman A. B. Interrater reliability of mHealth app rating measures: analysis of top depression and smoking cessation apps. JMIR 2016; 4(1), e15.
12. Powell A. C., Landman A. B., Bates D. W. In search of a few good apps. JAMA 2014; 311(18), 1851–1852.
13. Haller G., Haller D. M., Courvoisier D. S., Lovis C. Handheld vs. laptop computers for electronic data collection in clinical research: a crossover randomized trial, Journal of the American Medical Informatics Association 2009; 16, 651.
14. iPhone in Business. Security Overview, http://images.apple.com/iphone/business/docs/iPhone_Security.pdf (accessed 27 October 2016).
15. Palm webOS Security Overview for Enterprise, http://www.hpwebos.com/us/assets/pdfs/business/Palm_WhitePaper_Security.pdf (accessed 27 October 2016).
16. Device Administration, http://developer.android.com/guide/topics/admin/device-admin.html (accessed 27 October 2016).
17. Ozdalga E., Ozdalga A., Ahuja N. The smarphone in Medicine: a review of current and potential use among physicians and students. J. Med. Internet. Res. 2012; 14(5), e128.
18. Khoja S., Scott R., Husyin N., et al. Impact of simple conventional and Telehealth solutions on improving mental health in Afghanistan. J. Telemed. Telecare 2016; 22(8), 495–498.
19. Maulik P. K., Tewari A., Devarapalli S., Kallakuri S., Patel A. The Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health Project: Development and Testing of Electronic Decision Support System and Formative Research to Understand Perceptions about Mental Health in Rural India. PLoS ONE 2016; 11(10), e0164404. doi:10.1371/journal.pone.0164404
20. Kim J., Lim S., Min Y. H., Shin Y. W., Lee B., Sohn G., Jung K. H., Lee J. H., Son B. H., Ahn S. H., Shin S. Y., Lee J. W. Depression Screening Using Daily Mental-Health Ratings from a Smartphone Application for Breast Cancer Patients. J. Med. Internet. Res. 2016; 18(8), e216.
21. Kauer S. D., Reid S. C., Crooke A. H. D., Khor A., Hearps S. J. C., Jorm A. F., Sanci L., Patton G. Self-monitoring using mobile phones in the early stages of adolescent depression: randomized controlled trial. J. Med. Internet. Res. 2012; 14(3), e67.
22. Kobak K. A., Mundt J. C., Kennard B. Integrating technology into cognitive behavior therapy for adolescent depression: a pilot study. Ann. Gen. Psychiatry 2015; 14, 37.
23. Ly K. H., Janni E., Wiede R., Sedem M., Donker T., Carlberg P., Andersson G. Experiences of a guided smart-based behavioral activation therapy for depression: a qualitative study. Internet Interventions 2015; 2(1), 60–68.
24. Proudfoot J., Clarke J., Birch M. R., Whitton A. E., Parker G., Manicavasagar V., Harrison V., Christensen H., Hadzi-Pavlovic D. Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial. BMC Psychiatry 2013; 13, 132.
25. Watts S., Mackenzie A., Thomas C. H., et al. CBT for depression: a pilot RCT comparing mobile phone vs. Computer. BMC Psychiatry 2013; 13, 49.
26. Whittaker R. A., Merrz S., McDowell H., Stasiak K., Shepherd M., Dohertz I., Ameratunga S. A multimedia mobile phone based programme to prevent depression in adolescents, https://researchspace.auckland.ac.nz/handle/2292/18935 (accessed 27 October 2016).
27. Topolovec-Vranic J., Zhang S., Wong H., et al. Canadian Brain Injury and Violence Research Team. PLoS One 2015; 10(11), e0141699. doi:10.1371/journal.pone.0141699.
28. Winslow B. D., Chadderdon G. L., Dechmerowski S. J., et al. Development and Clinical Evaluation of an mHealth Application for Stress Management. Frontiers in Psychiatry 2016; 7, 130.
29. Ly K. H., Janni E., Wiede, R., Sedem, M., Donker, T., Carlberg, P., Andersson, G. Experiences of a guided smart-based behavioral activation therapy for depression: a qualitative study. Internet Interventions 2015; 2(1), 60–68.
30. Andersson G., Titov N. Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry 2014; 13(1), 4–11.
31. East M. L., Harvard B. C. Mental health mobile apps: from infusion to diffusion in the mental health social system. JMIR 2016; 2(1).
32. McCann E. HealthcareNews, http://www.healthcareitnews.com/news/novel-mhealth-app-detects-depression (accessed 27 October 2016).
33. Hedman E, Ljótsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness. Expert. Rev. Pharmacoecon Outcomes Res. 2012; 12745–12764.
34. Donker T., Petrie K., Proudfoot J., Clarke J., Birch M. R., Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J. Med. Internet Res. 2013; 15, 11.
35. Marešová P., Klímová B., Kuča K. Alzheimer disease: Cost cuts call for novel drugs development and national stratégy. Čes. slov. Farm. 2015; 64, 25–30.
36. Marešová P., Mohleská H., Kuča K. Drugs and Health Care Expenditure on the Aging Population. Čes. slov. Farm. 2015; 64, 173–177.
37. Marešová P., Klímová B., Krejcar O., Kuča K. Legislative aspects of the development of medical devices. Čes. slov. Farm. 2015; 64, 133–138.
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2017 Issue 2
Most read in this issue
- Targeted drug delivery system: potential application to resveratrol
- Mobile applications as good intervention tools for individuals with depression
- Separation of phenylalanine and methionine enantiomers by HPLC method: a comparison of stationary phase types
- The image of a good pharmacist in the works of Saladin di Ascoli and Valerius Cordus